Breaking News

Cambrex to Invest $16.5M in New R&D Facility and Expansion

R&D facility in Minneapolis expands capacity for small molecule development and manufacturing and expansion in Charles City adds QC lab and office space.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex is investing in a new, 21,000-sq.-ft. research and development facility in Minneapolis, MN, expanding capacity for small molecule development and manufacturing. Located near the Minneapolis–St. Paul Airport, the new facility will specialize in analytical and chemical development for pharmaceutical drug candidates and will operate as an extension of Cambrex’s flagship facility in Charles City, Iowa. Cambrex is expected to add approximately 40 new jobs over the next 2-3 years at the new si...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters